Literature DB >> 6067317

Field trial of a monovalent and of a bivalent mineral oil adjuvant trachoma vaccine in Taiwan school children.

R L Woolridge, J T Grayston, I H Chang, K H Cheng, C Y Yang, C Neave.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6067317     DOI： 10.1016/0002-9394(67)94158-x

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  23 in total

1.  Expression of MHC class II antigens by conjunctival epithelial cells in trachoma: implications concerning the pathogenesis of blinding disease.

Authors:  D C Mabey; R L Bailey; D Dunn; D Jones; J H Williams; H C Whittle; M E Ward
Journal:  J Clin Pathol       Date:  1991-04       Impact factor: 3.411

2.  Identification of Chlamydia trachomatis Antigens Recognized by T Cells From Highly Exposed Women Who Limit or Resist Genital Tract Infection.

Authors:  Ali N Russell; Xiaojing Zheng; Catherine M O'Connell; Harold C Wiesenfeld; Sharon L Hillier; Brandie D Taylor; Michelle D Picard; Jessica B Flechtner; Wujuan Zhong; Lauren C Frazer; Toni Darville
Journal:  J Infect Dis       Date:  2016-10-12       Impact factor: 5.226

3.  Trachoma vaccine field trials in The Gambia.

Authors:  S Sowa; J Sowa; L H Collier; W A Blyth
Journal:  J Hyg (Lond)       Date:  1969-12

4.  A vaccine formulated with the major outer membrane protein can protect C3H/HeN, a highly susceptible strain of mice, from a Chlamydia muridarum genital challenge.

Authors:  Sukumar Pal; Olga V Tatarenkova; Luis M de la Maza
Journal:  Immunology       Date:  2015-10-01       Impact factor: 7.397

5.  Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection.

Authors:  R P Morrison; K Feilzer; D B Tumas
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

6.  The influence of local antichlamydial antibody on the acquisition and persistence of human ocular chlamydial infection: IgG antibodies are not protective.

Authors:  R L Bailey; M Kajbaf; H C Whittle; M E Ward; D C Mabey
Journal:  Epidemiol Infect       Date:  1993-10       Impact factor: 2.451

7.  Chlamydia trachomatis native major outer membrane protein induces partial protection in nonhuman primates: implication for a trachoma transmission-blocking vaccine.

Authors:  Laszlo Kari; William M Whitmire; Deborah D Crane; Nathalie Reveneau; John H Carlson; Morgan M Goheen; Ellena M Peterson; Sukumar Pal; Luis M de la Maza; Harlan D Caldwell
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

8.  Identification of T-cell stimulatory antigens of Chlamydia trachomatis using synovial fluid-derived T-cell clones.

Authors:  A B Hassell; D J Reynolds; M Deacon; J S Gaston; J H Pearce
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397

9.  Vaccination with the recombinant major outer membrane protein elicits antibodies to the constant domains and induces cross-serovar protection against intranasal challenge with Chlamydia trachomatis.

Authors:  Delia F Tifrea; Pooja Ralli-Jain; Sukumar Pal; Luis M de la Maza
Journal:  Infect Immun       Date:  2013-03-11       Impact factor: 3.441

10.  Monoclonal antibodies define genus-specific, species-specific, and cross-reactive epitopes of the chlamydial 60-kilodalton heat shock protein (hsp60): specific immunodetection and purification of chlamydial hsp60.

Authors:  Y Yuan; K Lyng; Y X Zhang; D D Rockey; R P Morrison
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.